Psychosis to Pancreatitis: A Case Study Exploring the Risks of Hypertriglyceridemia in a Patient Treated With Olanzapine.

Document Type

Article

Publication Date

10-1-2024

Abstract

Olanzapine is an antipsychotic medication that is used in the management of schizophrenia and bipolar disorder, but it is not without any adverse effects. We present the following case of a 24-year-old man with a history of schizoaffective disorder, obesity, and anxiety, who developed hypertriglyceridemia-induced acute pancreatitis after six months on olanzapine. Despite his adherence to the medication, routine metabolic monitoring was not performed leading to a delayed diagnosis of hypertriglyceridemia and subsequent complications. The case underscores the critical need for regular metabolic monitoring in patients prescribed olanzapine to prevent severe adverse effects and guide timely intervention. Enhanced adherence to monitoring guidelines and consideration of alternative treatments may help mitigate such risks.

Publication Title

Cureus

Volume

16

Issue

10

First Page

70585

Last Page

70585

Link to Full Text

Share

COinS